Jules A A C Heuberger

30PUBLICATIONS
101CO-AUTHORS
PharmacogenomicsCentral nervous systemMolecular medicineCharacterisation of biological macromoleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 24, 2026
Sustained pharmacodynamic effects of S-ketamine on cortical excitability and resting-state brain activity: A randomized, placebo-controlled trial.

|May 14, 2026
Transcranial Magnetic Stimulation as a Translational Biomarker in Early-Phase Anti-Seizure Medication Development: A Randomized, Double-Blind, Placebo-Controlled Study in Generalized Epilepsy.

|Dec 16, 2025
Low-dose cannabidiol increases plasma concentrations of amitriptyline: A clinical drug-drug interaction study.

Andriy A Gorbenko, Titiaan E Post, Pamela K Strugala

|Aug 21, 2025
Cannabidiol Lacks Direct Effect on Cortical Excitability: A Randomized, Double Blind, Placebo Controlled, 3-Way Crossover Trial.

Andriy A Gorbenko, Catherine M K E de Cuba, Annika A de Goede

|Aug 18, 2025
Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial.

Brittany N Flores, Seungyoon B Yu, Isaac V Cohen

|May 15, 2025
Sentinel dosing: A proposed algorithm to guide decision making on which cohorts in early phase clinical pharmacology trials should use this approach.

Jules A A C Heuberger, Perry de Jongh, Ewoud-Jan van Hoogdalem

Pageof 5

Frequent Collaborators

15 joint publications

Geert Jan Groeneveld

6 joint publications

Annika A de Goede

6 joint publications

Titia Q Ruijs

5 joint publications

Catherine M K E de Cuba